APA (7th ed.) Citation

MB, O., K, S., FJ, B., A, O. B., C, V., BS, V., . . . ECW, B. (2020). Dual Epitope Targeting and Enhanced Hexamerization by DR5 Antibodies as a Novel Approach to Induce Potent Antitumor Activity Through DR5 Agonism. Molecular cancer therapeutics, 19(10), 2126. https://doi.org/10.1158/1535-7163.MCT-20-0044

Chicago Style (17th ed.) Citation

MB, Overdijk, et al. "Dual Epitope Targeting and Enhanced Hexamerization by DR5 Antibodies as a Novel Approach to Induce Potent Antitumor Activity Through DR5 Agonism." Molecular Cancer Therapeutics 19, no. 10 (2020): 2126. https://doi.org/10.1158/1535-7163.MCT-20-0044.

MLA (9th ed.) Citation

MB, Overdijk, et al. "Dual Epitope Targeting and Enhanced Hexamerization by DR5 Antibodies as a Novel Approach to Induce Potent Antitumor Activity Through DR5 Agonism." Molecular Cancer Therapeutics, vol. 19, no. 10, 2020, p. 2126, https://doi.org/10.1158/1535-7163.MCT-20-0044.